Latest Pharma Suchana News
Lupin gets U.S. FDA approval for Vigabatrin for Oral Solution USP.
Lupin Limited (Lupin) on March 11, 2022 announced…
NATCO Pharma Announced to Launch the First Generic Version of Revlimid® (Lenalidomide capsules), in the U.S. market.
NATCO Pharma Limited announces launch of the first…
Amneal Pharmaceutical receives USFDA approval for RELEUKO™ (filgrastim-ayow), a biosimilar referencing Neupogen.
Amneal Pharmaceutical receives USFDA approval for RELEUKO™ (filgrastim-ayow),…
Lupin Launches Sevelamer Hydrochloride Tablets in the United States
Global pharma major Lupin Limited (Lupin) announced the…
Zydus group announced its new brand identity- Cadila Healthcare to be known as Zydus Lifesciences.
The Zydus group announced its new brand identity…
Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Immediately Accretive Combination Creates a Unique Global, Vertically…
Biological E. Limited (BE) has announced that its CORBEVAX vaccine, has received EUA from India’s drug regulator for the 12 to 18-year age group.
Biological E. Limited (BE), one of the world’s…
Lupin gets FDA approval for SOLOSEC (secnidazole): a new drug for Adolescents to treat both Bacterial Vaginosis in Females and Trichomoniasis.
On February 17, 2022 Lupin announced about the…
